Inflammatory Bowel Disease Cohort in Nantes

Recruiting now

Conditions studied: Inflammatory Bowel Diseases

In brief

The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease

Key facts

Study ID

NCT06256393

Run by

Nantes University Hospital

People needed

360

Starts

2025-02-04

Expected to finish

2031-02-01

Last updated by the study team

2025-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients over 18 years of age;
• Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis;
• Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy;
• Patients who have given written consent to participate in the study and to keep biological samples for research purposes

You may not qualify if…

• Patients refusing to participate in the cohort;
• Patients with chronic inflammatory bowel disease quiescent at inclusion;
• Patients with a contraindication to general anaesthesia;
• Vulnerable patients (under court protection, curators, guardians);

Where it is running

• CHU de Nantes — Nantes, France (enrolling)
• Clinique Jules Verne — Nantes, France
• Hopital Privé du Confluent — Nantes, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.